Assist. Prof. Dr. Mai Kadry | Molecular chemistry | Best Researcher Award

Assist. Prof. Dr. Mai Kadry , National Research Center , Egypt

Mai Osman Mohamed Kadry is a dedicated biochemist, currently working as a researcher in the Therapeutic Chemistry Department at the National Research Centre, Cairo, Egypt. She holds a Doctorate in Biochemistry from Cairo University (2016) and an MSc in Pharmaceutical Sciences from Helwan University (2008). Her primary expertise lies in the field of therapeutic chemistry, with a focus on the biochemical effects of various treatments and their therapeutic potential. In addition to her research, Kadry has academic experience, having taught pharmacognosy at 6 October University. Her work often involves exploring the effects of nanotechnology, antioxidants, and herbal medicines on oxidative stress, toxicity, and cancer treatment. Kadry has contributed significantly to several projects and has published numerous research papers in high-impact journals. She is a well-rounded professional with strong training in various biochemical techniques and computational tools.

Publication Profile:

Scopus

Strengths for the Award:

1. Academic and Professional Background:
   • Mai Kadry holds a Doctoral degree in Biochemistry, showcasing a high level of academic commitment and specialization. Her focus on cutting-edge research topics such as the amelioration of titanium dioxide-induced oxidative injury, as well as her studies on pharmaceutical and biochemical sciences, highlights her expertise.
   • She has a significant teaching background in the academic field, particularly in the area of pharmacognosy, demonstrating her ability to contribute to the development of future researchers in the field.
2. Research Output and Publications:
   • Kadry has made substantial contributions to scientific literature, particularly in toxicology and therapeutic chemistry, with numerous research articles published in reputable journals. This includes studies on nano-formulations, the effects of titanium dioxide, and the therapeutic potential of resveratrol.
   • Her involvement in various high-impact research papers underlines her dedication to advancing her field. Additionally, the growing citation of her work further demonstrates the relevance and influence of her research.
3. Collaboration and Research Initiatives:
   • Kadry has actively participated in multiple innovative research projects at the National Research Centre, focusing on important areas such as nanobiotechnology, hepatocellular carcinoma, and diabetes treatment.
   • Her interdisciplinary approach, involving metabolomics, nanotechnology, and toxicity assessments, shows a broad and comprehensive research capacity, critical for addressing complex health challenges.
4. Training and Expertise:
   • Kadry has participated in numerous training courses, covering vital techniques like PCR, ELISA, HPLC, and bioinformatics, further strengthening her methodological skills.
   • Her expertise extends to a range of laboratory techniques that are essential for high-quality research in biochemistry and therapeutic chemistry, ensuring the reliability and depth of her scientific investigations.

Areas for Improvement:

1. Broader Recognition and Networking:
   • While Kadry has published extensively, there could be more emphasis on expanding her research network internationally. Increased participation in global conferences and collaborative research could further elevate her reputation.
2. Public Outreach and Communication:
   • Enhancing public awareness of her research, possibly through outreach programs or public lectures, could help bridge the gap between scientific research and society. This would make her research more accessible and valuable for a wider audience.
3. Interdisciplinary Application:
   • While Kadry has shown proficiency in fundamental biochemical research, exploring interdisciplinary applications of her work could bring new insights. For example, connecting her findings to practical medical treatments or developing clinical applications could offer significant real-world value.

Education:

Mai Osman Mohamed Kadry earned her Doctoral degree in Biochemistry from the Faculty of Pharmacy, Cairo University, in 2016, with a dissertation titled “Amelioration Of Nano-sized Titanium Dioxide-Induced Oxidative Injury in Mice by Some Antioxidants.” She holds a Master of Science in Pharmaceutical Sciences from Helwan University (2008), where her research focused on “The Possible Synergistic Role of Phytic and Catechin in Ameliorating the Deteriorative Biochemical Effects Induced By Carbon Tetrachloride in Rats.” Kadry completed her B.Sc. in Pharmaceutical Sciences at Ain Shams University in 2003, graduating with honors and a cumulative grade of Very Good. In addition to her academic qualifications, she has participated in various training courses, including bioinformatics, biosstatistics, scientific typewriting, and protein electrophoresis at the National Research Centre. Her education has provided a robust foundation in pharmaceutical science and biochemistry.

Experience:

Mai Osman Mohamed Kadry has over a decade of academic and research experience in biochemistry and pharmaceutical sciences. She worked as a researcher in the Therapeutic Chemistry Department at the National Research Centre, Cairo, Egypt, where she contributed to multiple research projects related to nanobiotechnology, metabolomics, and the therapeutic efficacy of herbal and chemical entities in treating cancer and diabetes. In her academic career, she taught pharmacognosy at 6 October University (2003-2004) and participated in academic development and quality assurance according to National Commission for Academic Accreditation standards. Kadry’s extensive research experience includes involvement in projects investigating the effects of nanoparticles, herbal medications, and novel chemical compounds on oxidative stress, liver injury, and cancer. She is proficient in a variety of biochemical laboratory techniques, including PCR, ELISA, and HPLC, which have been essential for her research efforts.

Research Focus:

Mai Osman Mohamed Kadry’s research focuses on the biochemical effects of various therapeutic agents, particularly in the areas of nanotechnology, antioxidants, and their role in combating oxidative stress, toxicity, and cancer. Her research aims to explore the potential of nanoparticles, such as titanium dioxide, in ameliorating damage caused by oxidative stress in mice models. She is deeply involved in projects related to the therapeutic properties of herbal medications and chemical entities in treating diseases like liver cancer and diabetes. Kadry is also interested in examining the synergistic effects of natural compounds, such as catechin and phytic acid, in mitigating biochemical damage induced by toxic substances like carbon tetrachloride. Her work further extends to studying autophagy and cell death pathways in response to chemotherapy and other therapeutic agents. Through her research, Kadry seeks to identify novel treatments and biomarkers that can improve the safety and efficacy of therapies for various diseases.

Publications Top Notes:

1. Titanium nanostructure mitigating doxorubicin–induced testicular toxicity in rats via regulating major autophagy signaling pathways 🧬💉
2. Inflammatory mediators-induced DNA damage in liver and brain injury: Therapeutic approach of 5-Methoy-N-acetyltryptamine 🧠🩺
3. Necroptosis and autophagy in cisplatinum-triggered nephrotoxicity: Novel insights regarding their prognostic and diagnostic potential 🩸🔬
4. Resveratrol-based nano-formulations as an emerging therapeutic strategy for ovarian carcinoma: autophagy stimulation and SIRT-1/Beclin/MMP-9/P53/AKT signaling 💊🌿
5. miR-122-IGF-1R signaling allied through the dysregulated lncRNA MALAT-1 expression in gastric carcinoma 🍽️🧬
6. Reciprocal crosslink among MeCP2/BDNF /CREB signaling pinpointed in autism spectrum disorder 🤯🔗
7. CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds 🧬💉
8. Collaboration of Hprt/K-RAS/c-Myc mutation in the oncogenesis of T-lymphocytic leukemia: a comparative study 🧬🩺
9. Thioctic acid shield against lipopolysaccharide depression and endoplasmic reticulum stress: GR7M/Homer/ATF6 signaling 💉🧬
10. Titanium dioxide nanostructure-loaded Adriamycin surmounts resistance in breast cancer therapy: ABCA/P53/C-myc crosstalk 💪💊

Conclusion:

Mai Osman Mohamed Kadry demonstrates remarkable potential and has made valuable contributions to the fields of biochemistry and therapeutic chemistry. Her academic background, research output, and active involvement in high-impact projects make her a strong contender for the “Best Researcher Award.” While there is room for growth in terms of global outreach and practical applications, her work undoubtedly plays a crucial role in advancing scientific knowledge, particularly in toxicology and the therapeutic use of nanomaterials. Therefore, she is highly deserving of consideration for this prestigious award.